Dr. Tom Sugarman, ED physician at Sutter Delta Medical Center in California and Senior Director of Government Affairs at Vituity discusses insights on the COVID-19 landscape, considerations for flu season preparation and how critical it is for hospitals and health systems to start preparing now prior to the onset of a potential COVID-19 surge. This includes accounting for the need to call in support from outside their health system, aligning on communications approach to and from the front lines, focusing on resiliency, and providing resources to support provider and staff wellness during these stressful times.
Returning guest, Dr. Maria Milla, MD, Section Chief, Nicklaus Children’s Pediatric Care Centers discusses the importance of flu vaccinations for children and their parents especially now in the COVID-19 environment.
The Incyte Ingenuity Award is an annual program that was created to support people living with graft-versus-host disease (GVHD). GVHD is a potentially life-threatening condition that occurs when donor immune cells attack the recipient’s organs and tissues after an allogeneic stem cell transplant. Dr. Areej El-Jawahri, MD, Director of the Bone Marrow Transplant Survivorship Program, Massachusetts General Cancer Center (MGCC) discusses the winning project from MGCC titled “Horizon Mobile App for Patients with Chronic GVHD”.
Aidan Foley, CEO at True Digital Surgery discusses the partnership with Aesculap, Inc., and the Aesculap Aeos® Robotic Digital Surgical Microscope that is now available in the U.S. The platform enables surgeons to execute precision movements in procedures including neurosurgery, spine, ear, nose, and throat operations, through a multi-axis robotic arm. This product is particularly beneficial for healthcare workers in the COVID-19 pandemic, as the Aeos’ immersive 3D heads-up display can be viewed simultaneously by the full surgical team in an operating room while safely wearing protective face shields. Further, the display helps to minimize the physical strain and pain reported by four out of five surgeons after a day of surgery by allowing them to stand upright, rather than hunched over traditional microscopes.
Lead developer, Yasmeen Almog, a data scientist on Amgen’s Digital Health and Innovation Team discusses Crystal Bone, a new digital health algorithm under development that may help doctors predict fracture risk in osteoporosis patients within a one to two-year time frame.
Returning guest, Dr. Mike Clayman, co-founder and CEO of Flexion Therapeutics discusses their FDA approved drug ZILRETTA® ((triamcinolone acetonide extended-release injectable suspension) for the treatment of osteoarthritis and how the company navigated the pandemic to keep meds in the hands of treating physicians and patients. He talks about how physicians are using ZILRETTA in place of elective surgeries, hence, the major increase in unit purchases from April to June 2020.
Dr. Ravi Jhaveri, MD, Associate Division Head of Pediatric Infectious Diseases at the Ann & Robert H. Lurie Children’s Hospital of Chicago and Professor of Pediatrics at Northwestern University Feinberg School of Medicine discusses how parents can prepare their families for this year’s flu season, while navigating alongside a global pandemic.
Mei Mei Hu, JD, co-founder and co-CEO and Peter Diamandis, MD, co-founder and vice chairman at COVAXX, a division of United Biomedical, discuss UB-612, which could be the first multitope peptide-based vaccine for COVID-19 based on a commercially proven platform that has shown promising efficacy in animals and is safe and scalable. In September 2020 the first healthy adult volunteers were dosed with UB-612 in the company’s Phase 1 trial in Taiwan.
Dr. Rahul Aras, CEO of Iterion Therapeutics, a clinical stage biotechnology company developing novel cancer therapeutics discusses the company’s lead product, Tegavivint, a unique nuclear β-catenin inhibitor, which is currently advancing to a Phase 2 clinical trial in patients with progressive desmoid tumors. The company will also pursue additional clinical programs in acute myeloid leukemia (AML), non-small cell lung cancer (NSCLC), and pediatric cancers this year and in 2021.
Tiffany and Wil Cook share their experience living and coping with the diagnosis of Duchenne Muscular Dystrophy (DMD). When Will was homeschooled he turned to video games and has made many friends around the world. Tiffany discusses her work as Family Resource Manager with CureDuchenne and the inaugural virtual gaming tournament hosted by CureDuchenne and PTC Therapeutics on October 10 to connect gamers and people living with DMD across the country.